Hair Loss Treatment Progress Report

Patient Information:

• Gender: Male
• Age: 40
• Hair Loss Stage: Norwood Hamilton 4+

Trial Period: 12 months

Treatment Plan:

1. HR23+ Hair Supplement
2. Minoxidil 5% (Topical Application)

Introduction

This report reviews the 12-month progress of a 40-year-old male patient undergoing treatment for androgenic alopecia, categorised as Norwood Hamilton Stage 4+. The prescribed treatment included HR23+ hair supplements and Minoxidil 5% for consistent application over a year.

Baseline Assessment

At the beginning of the trial, the patient displayed:

• Advanced hairline recession with deep temporal loss.
• Significant thinning at the crown.
• Noticeable scalp exposure in the mid-scalp region.

Treatment Protocol

1. HR23+ Hair Supplement: Taken daily to supply essential vitamins, minerals, and nutrients for follicle strength and growth.
2. Minoxidil 5%: Applied twice daily to stimulate follicular activity, improve scalp circulation, and combat hair loss progression.

Observations During Treatment

Month 1-3:

• Initial Shedding: Commonly observed with Minoxidil, as dormant follicles transitioned into an active growth phase.
• Crown Area: No visible changes yet.
• Side Effects: Mild scalp irritation, which subsided with improved application techniques.

Month 4-6:

• Reduced Shedding: Noticeable stabilisation of hair fall.
• Regrowth: Early signs of fine hair regrowth at the crown and mid-scalp regions.
• Hair Quality: Improved thickness and reduced brittleness.

Month 7-9:

• Crown Area: Significant regrowth, with fuller hair coverage.
• Mid-Scalp: Marked increase in density.
• Hairline: Limited improvement; regrowth noted primarily at the fringes of the receded area.
• Overall Health: Hair appeared healthier, shinier, and less prone to breakage.

Month 10-12:

• Crown and Vertex: Substantial improvement, with previously sparse areas showing notable density.
• Hairline: Some marginal progress, but not as significant as other areas.
• Shedding: Stabilized at minimal levels, indicating good follicular retention.
• Side Effects: No adverse effects reported.

Results Summary

• Crown Area: Excellent progress, with significantly improved density.
• Hairline: Marginal improvement; potential for enhancement with additional therapies.
• Overall Hair Quality: Thick, healthy, and resilient strands.
• Shedding: Virtually eliminated.

Conclusions

The combination of HR23+ supplement and Minoxidil 5% has delivered encouraging results over the 12-month period. The crown and mid-scalp areas have shown marked improvement, while the hairline remains a challenge. Consistent use of the treatment has led to healthier hair overall, with reduced shedding and increased density.

Recommendations

1. Continuation of Current Treatment: Extend the therapy for another 6-12 months to sustain and enhance gains.
2. Additional Therapies:
   • Miconeedling: To stimulate further follicle activity at the hairline.
   • Low-Level Laser Therapy (LLLT): To boost overall regrowth.
   • Platelet-Rich Plasma (PRP) Therapy: For targeted hairline improvement.
3. Regular Monitoring: Biannual follow-ups to track progress and adjust the treatment plan as needed.